The company’s decision to recall the batches comes one day after European regulators banned sales of valsartan after the impurity, N-nitrosodiethylamine was discovered.
Over the last year, several other drugmakers, including Major Pharmaceuticals, Solco Healthcare and Teva Pharmaceuticals, have recalled valsartan products under heightened scrutiny from regulators.
Read the full report here.
More articles on pharmacy:
5 recent pharma layoffs
Novartis has spent $15B to reinvent itself
AstraZeneca starts search for new CEO under pressure from stakeholders
